United States: MACRA Final Rule And Post-Election Questions

The Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) and the October 14, 2016 final rule from the Centers for Medicare & Medicaid Services (CMS) that implemented it (the Rule) brought a clear end to the plagued Medicare Sustainable Growth Rate methodology that brought uncertainty each year as to the next year’s Physician Fee Schedule. MACRA did away with the threat of catastrophic fee schedule cuts and fundamentally shifted how Medicare will pay physicians and other clinicians in the future, incorporating quality measurement and reporting into payments, and encouraging participation in value-based payment arrangements.

Of concern, however, is that even if the new administration and Congress do not make any modifications to MACRA, curtailment of the value-based programs and projects that are a key feature of the Affordable Care Act (the ACA) could result in the inability of physicians to participate in programs that would qualify them under MACRA for full fee schedule increases, and MACRA, in turn, would lose at least some of its ability to incentivize clinicians to transition away from fee-for-service payment.

This alert summarizes CMS’s final rule implementing MACRA, and offers considerations on what implications the election results bring.


Building on CMS’s proposed rule issued in April 2016 (the Proposed Rule) and effectuating the ambitious goals of MACRA, the Rule establishes the parameters of the “Quality Payment Program,” that consist of two payment tracks: the Merit-based Incentive Payment System (MIPS), based primarily on data tracking and reporting, and the Advanced Alternate Payment Models (APMs), based on participation in certain CMS-administered value-based payment programs or federal demonstration projects. Compared to the Proposed Rule, the Rule reflects CMS’s recognition that the Quality Payment Program will represent a shift for many clinicians, especially solo and small practices, with greater focus on reimbursement based on quality reporting and patient outcomes. For this reason, the Rule treats the first performance reporting period, calendar year (CY) 2017, as a “transition year,” which will allow for a gradual transition for clinicians into the Quality Payment Program. Clinicians must begin to submit certain, limited performance data to CMS in CY 2017, with reimbursement adjustments reflecting the CY 2017 data taking effect in CY 2019.

Clinicians Subject to MACRA

The Quality Payment Program applies to physicians, physician assistants, nurse practitioners, clinical nurse specialists, and certified registered nurse anesthetists—all whether in solo practice or in groups. However, clinicians and groups with annual Medicare Part B allowed charges below $30,000, or providing care for 100 or fewer Part B-enrolled Medicare beneficiaries, are excluded from participation in the Quality Payment Program.

Clinicians subject to MACRA may report data to CMS on an individual or group basis. Clinicians reporting on an individual basis (defined as a single National Provider Identifier (NPI) tied to a single Tax Identification Number (TIN)) will get a payment adjustment on the basis of their individual performance. Clinicians reporting on a group basis (with multiple NPIs sharing a common TIN) will get one payment adjustment based on the group’s performance. Clinicians wishing to register as a group for CY 2017 must do so no later than June 30, 2017.

Possibly anticipating alignment of individual or small groups of clinicians by contract in response to other value-based health care initiatives (such as the Bundled Payments for Care Improvement Initiative and the Comprehensive Care for Joint Replacement Model), CMS contemplates the formation of “virtual groups” composed of individual clinicians and small groups (not to exceed ten individual MIPS-eligible clinicians) for reporting and payment adjustment purposes. Unlike clinicians reporting on an actual group basis, virtual groups would not be required to share a single TIN.


MIPS replaces components of three existing Medicare programs: the Physician Quality Reporting System, the Physician Value-based Payment Modifier, and the Medicare Electronic Health Record Incentive Program for Eligible Professionals (commonly known as Meaningful Use). In place of these programs, MACRA establishes four performance categories under the single reporting framework of MIPS. The four categories are: Quality (evidence-based, specialty-specific standards); Improvement Activities (practice-based standards); Advancing Care Information (measuring the use of certified electronic health record technology (CEHRT)); and Cost.

For CY 2017, MIPS-participating clinicians who wish to be eligible to receive the maximum positive payment adjustment in CY 2019 (set at 4%) must report, at a minimum, the following data:

  • Quality – Clinicians must report at least six quality measures or one specialty-specific or subspecialty-specific quality measure set. CMS has identified hundreds of quality measures (e.g., percentage of patients aged 18 years and older who required an anastomotic leak intervention following gastric bypass or colectomy surgery, percentage of patients 18-85 years of age who had a diagnosis of hypertension and whose blood pressure was adequately controlled (<140/90mmHg) during the measurement period, and percentage of patients 65 years of age and older who were screened for future fall risk during the measurement period) and anticipates updating the quality measures on an annual basis.
  • Improvement Activities – Clinicians must engage in at least four improvement activities. CMS has identified nearly 100 improvement activities (e.g., seeing new and follow-up Medicaid patients in a timely manner, participation in the Consumer Assessment of Healthcare Providers and Systems Survey or other supplemental questionnaire items, and annual registration by the eligible clinician or group in the prescription drug monitoring program of the state where they practice) and anticipates updating the improvement activities from time to time.
  • Advancing Care Information – Clinician must report five required measures: security risk analysis; e-prescribing; providing patient access; sending summary of care; and requesting/accepting summary of care.
  • Cost – Clinicians will automatically report the required cost information by submitting claims for adjudication, as such information will be derived by CMS without clinician involvement. Cost will begin to be factored into provider payment adjustments during the CY 2018 reporting period.

Furthermore, because CY 2017 is a transition year, CMS has provided three options within MIPS to mitigate the potential for a negative payment adjustment in CY 2019:

  • Option One – Clinicians that report the full required data set forth above for at least a 90-day consecutive period during CY 2017.
  • Option Two – Clinicians that report more than one Quality measure, more than one Improvement Activity or the five required Advancing Care Information measures for at least a 90-day consecutive period during CY 2017.
  • Option Three – Clinicians that report one Quality measure, one Improvement Activity, or the five required Advancing Care Measures for any period of time during CY 2017.

Clinicians that fail to report even one measure or activity in CY 2017 will receive the full negative 4% payment adjustment in CY 2019.

Advanced APM Participation

As noted above, clinicians that otherwise would be eligible for MIPS can elect to participate in an Advanced APM instead. APMs include Center for Medicare and Medicaid Innovation (the CMMI) models, Shared Savings Program tracks or certain other federal demonstration projects. For an APM to be an Advanced APM it must also (1) require participants to use CEHRT; (2) provide payment for covered professional services based on quality measures comparable to those in the Quality category under MIPS; and (3) require that participating APM entities bear risk for monetary losses of more than a nominal amount (or be a Medical Home Model).

While CMS has not yet determined the specific qualifying Advanced APMs for CY 2017, it anticipates that at least the following models will qualify: Comprehensive End Stage Renal Disease Care Model (two-sided risk), Comprehensive Primary Care Plus (CPC+), Next Generation (Next Gen) ACOs, and Medicare Shared Savings Program (MSSP) Tracks 2 & 3.

Clinicians who are qualified Advanced APM participants (QPs) during the CY 2017 reporting period will receive a 5% incentive payment during the CY 2019 payment period, which is 1% higher than the maximum possible payment adjustment of 4% under MIPS. However, in order for clinicians to become QPs, and, thus, not be required to participate in and report under MIPS, the clinicians must either (1) receive at least 25% of their Medicare Part B covered professional service payments through an Advanced APM, or (2) receive at least 20% of their Medicare Part B patients through an Advanced APM. Clinicians should be aware that these thresholds will increase to 50% and 35% respectively for the CY 2019 reporting period; however, beginning in the CY 2019 performance reporting period, CMS leaves open the possibility that clinicians may satisfy these patient threshold requirements for Advanced APMs by also serving non-Medicare patients through a qualifying model.

Continued Evolution

CMS recognizes that the implementation of MACRA will be an iterative process that will continue to be shaped by stakeholder input. CMS has launched a new website, qpp.cms.gov, to educate clinicians about the Quality Payment Program and welcomes additional feedback from all health care stakeholders. Despite the Rule being issued in final form, CMS will continue to accept public comments on the Rule until December 19, 2016.

Impact of the Election on MACRA

With the election of Donald Trump and with Republican control of both houses of Congress, the Rule’s stability, as with other programs implementing health care reform, has been cast into question. Although there are reasons to expect that MACRA itself will not undergo significant revisions—unlike the ACA, MACRA was a bipartisan piece of legislation that was supported by 91% of Congress—any repeal of the ACA or retrenchment from administrative rulemaking could have a significant impact for clinicians looking to take part in Advanced APMs.

Specifically, one possible change may involve the CMMI and MSSP ACOs, which, as indicated above, were both established under the ACA. The CMMI is a testing center for innovative payment and service deliver models aimed at reducing Medicare and Medicaid expenditures while enhancing quality of care. The ACA gave CMS fairly broad authority to expand the scope and duration of a payment model being tested. Some of these CMMI models will qualify as Advanced APMs under the Rule, including Next Gen ACOs. In fact, all Advanced APMs cited in the Rule were initiated through the CMMI or established by the ACA. Through a repeal and replacement of the ACA, Congress may opt to assert more control over new payment models and either limit CMMI’s authority or do away with it all together. In fact, by way of a recent letter dated September 29, 2016, 179 members of Congress criticized many of the mandatory CMMI demonstration projects, and these concerns may carry over into future legislative initiatives. Any resulting statutory change to CMMI would thus reduce the number of Advanced APMs open for clinician participation and warrant further changes to the Rule—even if a larger transition from a fee-for-service system to a value-based payment system enjoys broad support on both sides of the aisle.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

In association with
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement

Mondaq.com (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of www.mondaq.com

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about Mondaq.com’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.


Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.


Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to unsubscribe@mondaq.com with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.


A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.


This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.


If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.


This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to webmaster@mondaq.com.

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to EditorialAdvisor@mondaq.com.

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at enquiries@mondaq.com.

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at problems@mondaq.com and we will use commercially reasonable efforts to determine and correct the problem promptly.